{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:42:45Z","timestamp":1792604565303,"version":"4.5.0"},"reference-count":320,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Diabetic kidney disease (DKD) is a leading cause of end-stage renal disease globally. Emerging research highlights the gut microbiota-gut-liver-kidney axis as a critical metabolic nexus linking dietary intake to DKD pathogenesis and progression. The gut microbiota, acting as a vast metabolic organ, transforms dietary components into key metabolites. Beneficial fermentation of fiber produces short-chain fatty acids (SCFAs) like butyrate, which exert anti-inflammatory and renal protective effects. Conversely, microbial metabolism of aromatic amino acids generates protein-bound uremic toxins, such as indoxyl sulfate and p-cresyl sulfate, which promote oxidative stress, inflammation, and fibrosis upon renal accumulation. DKD is characterized by intestinal barrier dysfunction (\u201cleaky gut\u201d) and metabolic endotoxemia, creating a vicious cycle that sustains systemic inflammation and kidney injury. Nutritional interventions targeting this axis show therapeutic promise. Dietary patterns (e.g., Mediterranean diet, increased plant protein) and specific prebiotics can modulate microbial composition, enhance SCFA production, and reduce uremic toxins. Natural bioactive compounds (e.g., berberine, quercetin, astragalus polysaccharides) and \u201cmedicine food homology\u201d substances demonstrate multi-target renoprotective effects by restoring microbiota balance, improving intestinal barrier integrity, and mitigating metabolic dysregulation. Future management strategies will leverage precision nutrition, utilizing multi-omics and artificial intelligence to design personalized dietary interventions based on individual microbiota profiles, offering a novel paradigm for comprehensive DKD care alongside conventional therapies.<\/jats:p>","DOI":"10.3389\/fnut.2026.1778473","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:50:58Z","timestamp":1777351858000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Gut microbiota-liver-kidney axis in diabetic kidney disease: mechanistic insights into amino acid metabolism and nutritional intervention strategies targeting natural bioactive compounds"],"prefix":"10.3389","volume":"13","author":[{"given":"Li-ya","family":"Sun","sequence":"first","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-yan","family":"Sun","sequence":"additional","affiliation":[{"name":"Liaoning Academy of Traditional Chinese Medicine (The Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine)","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Nan","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-ran","family":"Wang","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shi","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-feng","family":"Yang","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-feng","family":"Wang","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13098-023-01202-x","article-title":"Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis","volume":"15","author":"Fenta","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1513008","DOI":"10.3389\/fendo.2025.1513008","article-title":"Global burden of chronic kidney disease due to diabetes mellitus, 1990-2021, and projections to 2050","volume":"16","author":"Ma","year":"2025","journal-title":"Front Endocrinol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.kint.2022.10.030","article-title":"Targeting inflammation to treat diabetic kidney disease: the road to 2030","volume":"103","author":"Rayego-Mateos","year":"2023","journal-title":"Kidney Int"},{"key":"B6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.trsl.2023.11.002","article-title":"Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: a systematic review","volume":"265","author":"Das","year":"2024","journal-title":"Transl Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1124704","DOI":"10.3389\/fimmu.2023.1124704","article-title":"Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease","volume":"14","author":"Mao","year":"2023","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40795-023-00676-2","article-title":"High intake of dietary phytochemical index may be related to reducing risk of diabetic nephropathy: a case-control study","volume":"9","author":"Bahrampour","year":"2023","journal-title":"BMC Nutr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.4239\/wjd.v15.i3.475","article-title":"Dietary fiber intake and its association with diabetic kidney disease in American adults with diabetes: a cross-sectional study","volume":"15","author":"Jia","year":"2024","journal-title":"World J Diabetes."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1007\/s00125-024-06198-1","article-title":"The gut microbiota and diabetes: research, translation, and clinical applications - 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum","volume":"67","author":"Byndloss","year":"2024","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1359432","DOI":"10.3389\/fcimb.2024.1359432","article-title":"Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go","volume":"14","author":"Yu","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat Commun."},{"key":"B15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen","year":"2016","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1166685","DOI":"10.3389\/fphys.2023.1166685","article-title":"The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease","volume":"14","author":"Wu","year":"2023","journal-title":"Front Physiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s00467-016-3527-x","article-title":"The gut-kidney axis","volume":"32","author":"Evenepoel","year":"2017","journal-title":"Pediatr Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.2147\/DDDT.S150825","article-title":"Gut microbiota-derived short-chain fatty acids and kidney diseases","volume":"11","author":"Li","year":"2017","journal-title":"Drug Des Devel Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ckj\/sfab169","article-title":"Fiber intake and health in people with chronic kidney disease","volume":"15","author":"Su","year":"2022","journal-title":"Clin Kidney J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1681\/ASN.2019101029","article-title":"Dietary fiber protects against diabetic nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A","volume":"31","author":"Li","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/antiox12010123","article-title":"Antioxidant phytochemicals as potential therapy for diabetic complications","volume":"12","author":"Akpoveso","year":"2023","journal-title":"Antioxidants."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1522074","DOI":"10.3389\/fphar.2025.1522074","article-title":"Natural products in treating diabetic kidney disease: a visualized bibliometric analysis","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/13880209.2024.2351946","article-title":"Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota","volume":"62","author":"Wu","year":"2024","journal-title":"Pharm Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1080\/0886022X.2022.2079522","article-title":"Probiotics improve renal function, glucose, lipids, inflammation and oxidative stress in diabetic kidney disease: a systematic review and meta-analysis","volume":"44","author":"Dai","year":"2022","journal-title":"Ren Fail."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.3390\/ijms23073842","article-title":"Fecal microbiota transplant in a pre-clinical model of type 2 diabetes mellitus, obesity and diabetic kidney disease","volume":"23","author":"Bastos","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1002\/1873-3468.14966","article-title":"Host-diet-microbiota interplay in intestinal nutrition and health","volume":"598","author":"Ignatiou","year":"2024","journal-title":"FEBS Lett."},{"key":"B28","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nature25973","article-title":"Environment dominates over host genetics in shaping human gut microbiota","volume":"555","author":"Rothschild","year":"2018","journal-title":"Nature."},{"key":"B29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/ajcn\/nqy041","article-title":"Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis","volume":"107","author":"So","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1387394","DOI":"10.3389\/fnut.2024.1387394","article-title":"Dietary patterns interfere with gut microbiota to combat obesity","volume":"11","author":"Lou","year":"2024","journal-title":"Front Nutr"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1136\/gutjnl-2020-323715","article-title":"Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health","volume":"71","author":"Jardon","year":"2022","journal-title":"Gut"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1136\/gutjnl-2019-319654","article-title":"Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries","volume":"69","author":"Ghosh","year":"2020","journal-title":"Gut."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes","volume":"359","author":"Zhao","year":"2018","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2021","journal-title":"Gut."},{"key":"B35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4161\/gmic.19897","article-title":"Microbial degradation of complex carbohydrates in the gut","volume":"3","author":"Flint","year":"2012","journal-title":"Gut Microbes."},{"key":"B36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.copbio.2012.08.005","article-title":"Bacteria as vitamin suppliers to their host: a gut microbiota perspective","volume":"24","author":"LeBlanc","year":"2013","journal-title":"Curr Opin Biotechnol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat Rev Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40168-021-01101-1","article-title":"Review: microbial transformations of human bile acids","volume":"9","author":"Guzior","year":"2021","journal-title":"Microbiome."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"den Besten","year":"2013","journal-title":"J Lipid Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41522-024-00533-5","article-title":"Investigating the response of the butyrate production potential to major fibers in dietary intervention studies","volume":"10","author":"Van-Wehle","year":"2024","journal-title":"NPJ Biofilms Microbiomes."},{"key":"B42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/19490976.2017.1290756","article-title":"Dietary fiber and prebiotics and the gastrointestinal microbiota","volume":"8","author":"Holscher","year":"2017","journal-title":"Gut Microbes."},{"key":"B43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/microorganisms7010019","article-title":"Microbial fermentation of dietary protein: an important factor in diet-microbe-host interaction","volume":"7","author":"Diether","year":"2019","journal-title":"Microorganisms."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1039\/D3FO04187E","article-title":"Protein combined with certain dietary fibers increases butyrate production in gut microbiota fermentation","volume":"15","author":"Jackson","year":"2024","journal-title":"Food Funct."},{"key":"B46","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1530\/JOE-17-0542","article-title":"Gut-brain signaling in energy homeostasis: the unexpected role of microbiota-derived succinate","volume":"236","author":"de Vadder","year":"2018","journal-title":"J Endocrinol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev Endocr Metab Disord."},{"key":"B48","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ismej.2013.155","article-title":"High-fat diet alters gut microbiota physiology in mice","volume":"8","author":"Daniel","year":"2014","journal-title":"ISME J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.cell.2024.03.014","article-title":"Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria","volume":"187","author":"Li","year":"2024","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0038223","DOI":"10.1128\/spectrum.00382-23","article-title":"The intestinal microbiota composition in early and late stages of diabetic kidney disease","volume":"11","author":"Zhang","year":"2023","journal-title":"Microbiol Spectr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.micpath.2016.02.005","article-title":"Akkermansia muciniphila and its role in regulating host functions","volume":"106","author":"Derrien","year":"2017","journal-title":"Microb Pathog."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1038\/ismej.2013.89","article-title":"A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice","volume":"7","author":"Marcobal","year":"2013","journal-title":"ISME J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","article-title":"The use of animal models in diabetes research","volume":"166","author":"King","year":"2012","journal-title":"Br J Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","article-title":"The interaction between bacteria and bile","volume":"29","author":"Begley","year":"2005","journal-title":"FEMS Microbiol Rev."},{"key":"B55","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1113\/JP272613","article-title":"Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study","volume":"595","author":"Boets","year":"2017","journal-title":"J Physiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature18309","article-title":"Acetate mediates a microbiome-brain-\u03b2-cell axis to promote metabolic syndrome","volume":"534","author":"Perry","year":"2016","journal-title":"Nature."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e12191","DOI":"10.1371\/journal.pone.0012191","article-title":"High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse","volume":"5","author":"Ding","year":"2010","journal-title":"PLoS ONE."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes."},{"key":"B59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther."},{"key":"B60","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","article-title":"The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon","volume":"13","author":"Donohoe","year":"2011","journal-title":"Cell Metab."},{"key":"B61","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/biom15040469","article-title":"The role of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and other metabolic diseases","volume":"15","author":"M\u00fcnte","year":"2025","journal-title":"Biomolecules."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr Physiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat Rev Drug Discov."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J Lipid Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1577724","DOI":"10.3389\/fmicb.2025.1577724","article-title":"Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease","volume":"16","author":"Buchynskyi","year":"2025","journal-title":"Front Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol Cell."},{"key":"B69","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"B70","doi-asserted-by":"publisher","first-page":"102530","DOI":"10.1016\/j.jbc.2022.102530","article-title":"The role of FXR and TGR5 in reversing and preventing progression of Western diet-induced hepatic steatosis, inflammation, and fibrosis in mice","volume":"298","author":"Wang","year":"2022","journal-title":"J Biol Chem."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1073\/pnas.0506982103","article-title":"Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B72","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J Biol Chem."},{"key":"B73","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature."},{"key":"B74","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab."},{"key":"B75","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","article-title":"The bile acid TGR5 membrane receptor: from basic research to clinical application","volume":"46","author":"Duboc","year":"2014","journal-title":"Dig Liver Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"609060","DOI":"10.3389\/fimmu.2020.609060","article-title":"TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation","volume":"11","author":"Shi","year":"2020","journal-title":"Front Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell."},{"key":"B78","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes."},{"key":"B79","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s13668-018-0248-8","article-title":"Role of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health","volume":"7","author":"Chambers","year":"2018","journal-title":"Curr Nutr Rep."},{"key":"B80","doi-asserted-by":"publisher","first-page":"11312","DOI":"10.1074\/jbc.M211609200","article-title":"The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids","volume":"278","author":"Brown","year":"2003","journal-title":"J Biol Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2337\/db11-1019","article-title":"Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2","volume":"61","author":"Tolhurst","year":"2012","journal-title":"Diabetes."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2393270","DOI":"10.1080\/19490976.2024.2393270","article-title":"The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease","volume":"16","author":"Hays","year":"2024","journal-title":"Gut Microbes."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/133.7.2485S","article-title":"Inhibition of histone deacetylase activity by butyrate","author":"Davie","year":"2003","journal-title":"J Nutr"},{"key":"B84","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.09.014","article-title":"Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity","author":"Chun","year":"2019","journal-title":"Immunity"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp Mol Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"717925","DOI":"10.3389\/fnut.2021.717925","article-title":"The role of intestinal permeability in gastrointestinal disorders and current methods of evaluation","volume":"8","author":"Vanuytsel","year":"2021","journal-title":"Front Nutr."},{"key":"B88","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern Emerg Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","article-title":"Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis","volume":"292","author":"Brun","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1120168","DOI":"10.3389\/fnut.2023.1120168","article-title":"Enhancing intestinal barrier efficiency: a novel metabolic diseases therapy","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Nutr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.biochi.2015.06.020","article-title":"Metabolic endotoxemia with obesity: is it real and is it relevant?","volume":"124","author":"Boutagy","year":"2016","journal-title":"Biochimie."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes."},{"key":"B93","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.4049\/jimmunol.1402598","article-title":"Lipopolysaccharide regulation of intestinal tight junction permeability is mediated by TLR4 signal transduction pathway activation of FAK and MyD88","volume":"195","author":"Guo","year":"2015","journal-title":"J Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1380713","DOI":"10.3389\/fphys.2024.1380713","article-title":"Intestinal barrier permeability: the influence of gut microbiota, nutrition, and exercise","volume":"15","author":"Dmytriv","year":"2024","journal-title":"Front Physiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12967-017-1175-y","article-title":"Influence of diet on the gut microbiome and implications for human health","volume":"15","author":"Singh","year":"2017","journal-title":"J Transl Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","article-title":"Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function","volume":"17","author":"Kelly","year":"2015","journal-title":"Cell Host Microbe."},{"key":"B97","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00592-019-01316-7","article-title":"Understanding the gut-kidney axis among biopsy-proven diabetic nephropathy, type 2 diabetes mellitus and healthy controls: an analysis of the gut microbiota composition","volume":"56","author":"Tao","year":"2019","journal-title":"Acta Diabetol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang","year":"2020","journal-title":"Gut."},{"key":"B100","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int."},{"key":"B101","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"Ramezani","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/toxins10040155","article-title":"The role of gut microbiota and diet on uremic retention solutes production in the context of chronic kidney disease","volume":"10","author":"Koppe","year":"2018","journal-title":"Toxins."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e0134311","DOI":"10.1371\/journal.pone.0134311","article-title":"Gut-microbiota-metabolite axis in early renal function decline","volume":"10","author":"Barrios","year":"2015","journal-title":"PLoS ONE."},{"key":"B104","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/ndt\/gfq818","article-title":"The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression","volume":"26","author":"Meijers","year":"2011","journal-title":"Nephrol Dial Transplant."},{"key":"B105","doi-asserted-by":"publisher","first-page":"872988","DOI":"10.3389\/fphar.2022.872988","article-title":"Characteristics of serum metabolites and gut microbiota in diabetic kidney disease","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.3390\/nu13113721","article-title":"Plant-based versus animal-based low protein diets in the management of chronic kidney disease","volume":"13","author":"Mocanu","year":"2021","journal-title":"Nutrients."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/ki.2010.348","article-title":"Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet","volume":"78","author":"Wesson","year":"2010","journal-title":"Kidney Int."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.3390\/nu12071931","article-title":"Plant-dominant low-protein diet for conservative management of chronic kidney disease","volume":"12","author":"Kalantar-Zadeh","year":"2020","journal-title":"Nutrients."},{"key":"B109","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1080\/10408398.2021.1996331","article-title":"Dietary strategies for gut-derived protein-bound uremic toxins and cardio-metabolic risk factors in chronic kidney disease: a focus on dietary fibers","volume":"63","author":"Melekoglu","year":"2023","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B110","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe."},{"key":"B111","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1073\/pnas.0906112107","article-title":"The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation","volume":"107","author":"Bansal","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1038\/s41467-019-09735-4","article-title":"Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease","volume":"10","author":"Kikuchi","year":"2019","journal-title":"Nat Commun."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1097\/01.ASN.0000022017.96399.B2","article-title":"Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity","volume":"13","author":"Enomoto","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.kint.2020.10.001","article-title":"Corrigendum to \u201cVanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability\u201d. Kidney Int. 2003;63:1934-1943","volume":"98","author":"Vanholder","year":"2020","journal-title":"Kidney Int"},{"key":"B115","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/toxins12110684","article-title":"Indoxyl sulfate, a tubular toxin, contributes to the development of chronic kidney disease","volume":"12","author":"Cheng","year":"2020","journal-title":"Toxins."},{"key":"B116","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.lfs.2012.01.013","article-title":"Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-\u03baB, p53, ERK, and JNK in proximal tubular cells","volume":"90","author":"Shimizu","year":"2012","journal-title":"Life Sci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/j.jrn.2021.09.007","article-title":"The accumulation of gut microbiome-derived indoxyl sulfate and P-cresyl sulfate in patients with end-stage renal disease","volume":"32","author":"Lin","year":"2022","journal-title":"J Ren Nutr."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000476074","article-title":"Aryl hydrocarbon receptor activation in chronic kidney disease: role of uremic toxins","volume":"137","author":"Brito","year":"2017"},{"key":"B119","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s00018-020-03645-1","article-title":"Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation","volume":"78","author":"Liu","year":"2021","journal-title":"Cell Mol Life Sci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","article-title":"Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals","volume":"43","author":"Denison","year":"2003","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"e2402066","DOI":"10.1002\/advs.202402066","article-title":"Uremic toxin receptor AhR facilitates renal senescence and fibrosis via suppressing mitochondrial biogenesis","volume":"11","author":"Xie","year":"2024","journal-title":"Adv Sci."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2009.402","article-title":"Uremic toxins originating from colonic microbial metabolism","author":"Evenepoel","year":"2009","journal-title":"Kidney Int Suppl."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1200391","DOI":"10.3389\/fendo.2023.1200391","article-title":"Microbial metabolite p-cresol inhibits gut hormone expression and regulates small intestinal transit in mice","volume":"14","author":"Toft","year":"2023","journal-title":"Front Endocrinol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3390\/genes14061257","article-title":"Possible effects of uremic toxins p-cresol, indoxyl sulfate, p-cresyl sulfate on the development and progression of colon cancer in patients with chronic renal failure","volume":"14","author":"Di Paola","year":"2023","journal-title":"Genes."},{"key":"B126","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","article-title":"A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors","volume":"180","author":"Nemet","year":"2020","journal-title":"Cell"},{"key":"B127","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chom.2022.11.015","article-title":"Two distinct gut microbial pathways contribute to meta-organismal production of phenylacetylglutamine with links to cardiovascular disease","volume":"31","author":"Zhu","year":"2023","journal-title":"Cell Host Microbe"},{"key":"B128","doi-asserted-by":"publisher","first-page":"e009972","DOI":"10.1161\/CIRCHEARTFAILURE.122.009972","article-title":"Gut microbiota-generated phenylacetylglutamine and heart failure","volume":"16","author":"Romano","year":"2023","journal-title":"Circ Heart Fail."},{"key":"B129","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1681\/ASN.2015121302","article-title":"Microbiota-derived phenylacetylglutamine associates with overall mortality and cardiovascular disease in patients with CKD","volume":"27","author":"Poesen","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"954","DOI":"10.3390\/ijms19040954","article-title":"Branched chain amino acids: beyond nutrition metabolism","volume":"19","author":"Nie","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell."},{"key":"B132","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat Rev Endocrinol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metab."},{"key":"B134","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.freeradbiomed.2017.01.009","article-title":"High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation","volume":"104","author":"Zhenyukh","year":"2017","journal-title":"Free Radic Biol Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1239838","DOI":"10.3389\/fnut.2023.1239838","article-title":"Active role of amino acid metabolism in early diagnosis and treatment of diabetic kidney disease","volume":"10","author":"Li","year":"2023","journal-title":"Front Nutr."},{"key":"B136","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.3390\/nu14163345","article-title":"Impaired amino acid metabolism and its correlation with diabetic kidney disease progression in type 2 diabetes mellitus","volume":"14","author":"Zhu","year":"2022","journal-title":"Nutrients."},{"key":"B137","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3390\/jcm12186053","article-title":"Depiction of branched-chain amino acids (BCAAs) in diabetes with a focus on diabetic microvascular complications","volume":"12","author":"Tanase","year":"2023","journal-title":"J Clin Med."},{"key":"B138","doi-asserted-by":"publisher","first-page":"e0234422","DOI":"10.1128\/spectrum.02344-22","article-title":"Gut microbial genes and metabolism for methionine and branched-chain amino acids in diabetic nephropathy","volume":"11","author":"Kim","year":"2023","journal-title":"Microbiol Spectr."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1269633","DOI":"10.3389\/fendo.2023.1269633","article-title":"Serum branched chain amino acids: an effective indicator of diabetic kidney disease","volume":"14","author":"Liu","year":"2023","journal-title":"Front Endocrinol."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/136.6.1652S","article-title":"Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism","author":"Stipanuk","year":"2006","journal-title":"J Nutr"},{"key":"B141","doi-asserted-by":"publisher","first-page":"114694","DOI":"10.1016\/j.biopha.2023.114694","article-title":"GYY4137, a HS donor, ameliorates kidney injuries in diabetic mice by modifying renal ROS-associated enzymes","volume":"162","author":"Chen","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B142","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1152\/physrev.00017.2011","article-title":"Physiological implications of hydrogen sulfide: a whiff exploration that blossomed","volume":"92","author":"Wang","year":"2012","journal-title":"Physiol Rev."},{"key":"B143","doi-asserted-by":"publisher","first-page":"28827","DOI":"10.1074\/jbc.M114.596593","article-title":"Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model","volume":"289","author":"Zhou","year":"2014","journal-title":"J Biol Chem."},{"key":"B144","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1080\/0886022X.2022.2107936","article-title":"The roles of hydrogen sulfide in renal physiology and disease states","volume":"44","author":"Feng","year":"2022","journal-title":"Ren Fail."},{"key":"B145","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"Am J Pathol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1109445","DOI":"10.3389\/fcvm.2022.1109445","article-title":"Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis","volume":"9","author":"Yuan","year":"2022","journal-title":"Front Cardiovasc Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12882-022-03045-6","article-title":"Relationship between plasma homocysteine and chronic kidney disease in US patients with type 2 diabetes mellitus: a cross-sectional study","volume":"23","author":"Shen","year":"2022","journal-title":"BMC Nephrol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"e40357","DOI":"10.7759\/cureus.40357","article-title":"Plasma homocysteine levels and cardiovascular events in patients with end-stage renal disease: a systematic review","volume":"15","author":"Alsolami","year":"2023","journal-title":"Cureus."},{"key":"B149","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1172\/JCI44774","article-title":"Role of mTOR in podocyte function and diabetic nephropathy in humans and mice","volume":"121","author":"G\u00f6del","year":"2011","journal-title":"J Clin Invest."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2217\/fmb-2017-0059","article-title":"Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease","volume":"12","author":"Esgalhado","year":"2017","journal-title":"Future Microbiol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1053\/j.jrn.2024.09.005","article-title":"Effects of high amylose-resistant starch on gut microbiota and uremic toxin levels in patients with stage-G3a-G4 chronic kidney disease: a randomized trial","volume":"35","author":"Headley","year":"2025","journal-title":"J Ren Nutr."},{"key":"B152","doi-asserted-by":"publisher","first-page":"2473506","DOI":"10.1080\/19490976.2025.2473506","article-title":"Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease","volume":"17","author":"Wu","year":"2025","journal-title":"Gut Microbes."},{"key":"B153","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.numecd.2021.04.021","article-title":"Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: meta-analysis of profiling metabolomics studies","volume":"31","author":"Roointan","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B154","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/jpm13030556","article-title":"Diagnostic value of the combined measurement of serum HCY and NRG4 in type 2 diabetes mellitus with early complicating diabetic nephropathy","volume":"13","author":"Ding","year":"2023","journal-title":"J Pers Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13063-025-08755-4","article-title":"The gut microbiota and diabetic nephropathy: an observational study review and bidirectional Mendelian randomization study","volume":"26","author":"Han","year":"2025","journal-title":"Trials."},{"key":"B156","doi-asserted-by":"publisher","first-page":"F824","DOI":"10.1152\/ajprenal.00314.2017","article-title":"Canagliflozin reduces plasma uremic toxins and alters the intestinal microbiota composition in a chronic kidney disease mouse model","volume":"315","author":"Mishima","year":"2018","journal-title":"Am J Physiol Renal Physiol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat Med."},{"key":"B158","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2337\/dc19-0048","article-title":"Utility of plasma concentration of trimethylamine N-oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes","volume":"42","author":"Winther","year":"2019","journal-title":"Diabetes Care."},{"key":"B160","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1053\/j.ajkd.2005.12.036","article-title":"A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD","volume":"47","author":"Schulman","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"B161","doi-asserted-by":"publisher","first-page":"101367","DOI":"10.1016\/j.molmet.2021.101367","article-title":"Serum integrative omics reveals the landscape of human diabetic kidney disease","volume":"54","author":"Liu","year":"2021","journal-title":"Mol Metab."},{"key":"B162","doi-asserted-by":"publisher","first-page":"819311","DOI":"10.3389\/fmed.2022.819311","article-title":"Serum metabolomics benefits discrimination kidney disease development in type 2 diabetes patients","volume":"9","author":"Peng","year":"2022","journal-title":"Front Med."},{"key":"B163","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.3390\/jcm8101718","article-title":"Effects and safety of an oral adsorbent on chronic kidney disease progression: a systematic review and meta-analysis","volume":"8","author":"Chen","year":"2019","journal-title":"J Clin Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrneph.2017.30","article-title":"Metabolomics for clinical use and research in chronic kidney disease","volume":"13","author":"Hocher","year":"2017","journal-title":"Nat Rev Nephrol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1021\/acs.analchem.6b02930","article-title":"Interlaboratory reproducibility of a targeted metabolomics platform for analysis of human serum and plasma","volume":"89","author":"Siskos","year":"2017","journal-title":"Anal Chem."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"B168","doi-asserted-by":"publisher","first-page":"2517402","DOI":"10.1080\/0886022X.2025.2517402","article-title":"Gut microbiota implication in diabetic kidney disease: mechanisms and novel therapeutic strategies","volume":"47","author":"Zhang","year":"2025","journal-title":"Ren Fail."},{"key":"B169","doi-asserted-by":"publisher","first-page":"121414","DOI":"10.1016\/j.lfs.2023.121414","article-title":"Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: current status and future perspective","volume":"316","author":"Das","year":"2023","journal-title":"Life Sci."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1161\/ATVBAHA.120.314139","article-title":"Targeted inhibition of gut microbial trimethylamine N-oxide production reduces renal tubulointerstitial fibrosis and functional impairment in a murine model of chronic kidney disease","volume":"40","author":"Gupta","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1053\/j.ajkd.2022.02.016","article-title":"Association of uremic solutes with cardiovascular death in diabetic kidney disease","volume":"80","author":"Sapa","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"B172","doi-asserted-by":"publisher","first-page":"682482","DOI":"10.3389\/fphys.2021.682482","article-title":"Trimethylamine N-oxide exacerbates renal inflammation and fibrosis in rats with diabetic kidney disease","volume":"12","author":"Fang","year":"2021","journal-title":"Front Physiol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1053\/j.ajkd.2015.09.027","article-title":"Role of the gut microbiome in uremia: a potential therapeutic target","volume":"67","author":"Ramezani","year":"2016","journal-title":"Am J Kidney Dis."},{"key":"B174","doi-asserted-by":"publisher","first-page":"112927","DOI":"10.1016\/j.diabres.2025.112927","article-title":"Association of the metabolic dysfunction-associated steatotic liver disease with cardiovascular and kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study","volume":"229","author":"Ren","year":"2025","journal-title":"Diabetes Res Clin Pract."},{"key":"B175","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.3748\/wjg.v28.i39.5691","article-title":"Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: epidemiology, pathophysiologic mechanisms, and treatment considerations","volume":"28","author":"Theofilis","year":"2022","journal-title":"World J Gastroenterol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"110563","DOI":"10.1016\/j.diabres.2023.110563","article-title":"Metabolic dysfunction-associated fatty liver disease can significantly increase the risk of chronic kidney disease in adults with type 2 diabetes","volume":"197","author":"Wei","year":"2023","journal-title":"Diabetes Res Clin Pract."},{"key":"B177","doi-asserted-by":"publisher","first-page":"sfaf260","DOI":"10.1093\/ckj\/sfaf260","article-title":"The impact of metabolic dysfunction-associated steatotic liver disease (MASH) on the high risk of cardiovascular disease in CKD: interconnections and management","volume":"18","author":"Moncho","year":"2025","journal-title":"Clin Kidney J"},{"key":"B178","doi-asserted-by":"publisher","first-page":"175219","DOI":"10.1016\/j.ejphar.2022.175219","article-title":"Crosstalk between the liver and kidney in diabetic nephropathy","volume":"931","author":"Yang","year":"2022","journal-title":"Eur J Pharmacol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"e70163","DOI":"10.1111\/1753-0407.70163","article-title":"Diabetic kidney and liver disease concepts","volume":"17","author":"Bloomgarden","year":"2025","journal-title":"J Diabetes."},{"key":"B180","doi-asserted-by":"publisher","first-page":"1333429","DOI":"10.3389\/fimmu.2024.1333429","article-title":"Critical role of FGF21 in diabetic kidney disease: from energy metabolism to innate immunity","volume":"15","author":"Liang","year":"2024","journal-title":"Front Immunol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1038\/s41467-022-31476-0","article-title":"Renal UTX-PHGDH-serine axis regulates metabolic disorders in the kidney and liver","volume":"13","author":"Chen","year":"2022","journal-title":"Nat Commun."},{"key":"B182","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13098-025-01796-4","article-title":"CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease","volume":"17","author":"Godoy-Matos","year":"2025","journal-title":"Diabetol Metab Syndr."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1207132","DOI":"10.3389\/fmicb.2023.1207132","article-title":"The roles of gut microbiota and its metabolites in diabetic nephropathy","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Microbiol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1336402","DOI":"10.3389\/fendo.2024.1336402","article-title":"Lipid metabolism disorder in diabetic kidney disease","volume":"15","author":"Han","year":"2024","journal-title":"Front Endocrinol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1661037","DOI":"10.3389\/fendo.2025.1661037","article-title":"Gut microbiota dysbiosis in diabetic nephropathy: mechanisms and therapeutic targeting via the gut-kidney axis","volume":"16","author":"Jiang","year":"2025","journal-title":"Front Endocrinol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1093\/ndt\/gfr624","article-title":"Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation","volume":"27","author":"Vaziri","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1681\/ASN.2021060843","article-title":"Intestinal bacterial translocation contributes to diabetic kidney disease","volume":"33","author":"Linh","year":"2022","journal-title":"J Am Soc Nephrol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1681\/ASN.2010111210","article-title":"Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy","volume":"23","author":"Lin","year":"2012","journal-title":"J Am Soc Nephrol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"101484","DOI":"10.1016\/j.beem.2021.101484","article-title":"Intestinal microbiota and diabetic kidney diseases: the role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression","volume":"35","author":"Mosterd","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41598-017-01387-y","article-title":"Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep."},{"key":"B191","doi-asserted-by":"publisher","first-page":"e24062","DOI":"10.1002\/jcla.24062","article-title":"The change of gut microbiota-derived short-chain fatty acids in diabetic kidney disease","volume":"35","author":"Zhong","year":"2021","journal-title":"J Clin Lab Anal."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1080456","DOI":"10.3389\/fimmu.2022.1080456","article-title":"The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease","volume":"13","author":"Tao","year":"2022","journal-title":"Front Immunol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"4074832","DOI":"10.1155\/2020\/4074832","article-title":"Short-chain fatty acids ameliorate diabetic nephropathy via GPR43-mediated inhibition of oxidative stress and NF-\u03baB signaling","volume":"2020","author":"Huang","year":"2020","journal-title":"Oxid Med Cell Longev."},{"key":"B194","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/nu17050772","article-title":"Beneficial effects of butyrate on kidney disease","volume":"17","author":"Diep","year":"2025","journal-title":"Nutrients"},{"key":"B195","doi-asserted-by":"publisher","first-page":"10462","DOI":"10.1096\/fj.202000431R","article-title":"Butyrate alleviates diabetic kidney disease by mediating the miR-7a-5p\/P311\/TGF-\u03b21 pathway","volume":"34","author":"Du","year":"2020","journal-title":"FASEB J."},{"key":"B196","doi-asserted-by":"publisher","first-page":"7643322","DOI":"10.1155\/2022\/7643322","article-title":"Sodium butyrate attenuates diabetic kidney disease partially via histone butyrylation modification","volume":"2022","author":"Zhou","year":"2022","journal-title":"Mediators Inflamm."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.ijbiomac.2019.03.242","article-title":"Modulating the gut microbiota and inflammation is involved in the effect of Bupleurum polysaccharides against diabetic nephropathy in mice","volume":"132","author":"Feng","year":"2019","journal-title":"Int J Biol Macromol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00592-022-01870-7","article-title":"Short chain fatty acids for the risk of diabetic nephropathy in type 2 diabetes patients","volume":"59","author":"Li","year":"2022","journal-title":"Acta Diabetol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.2147\/DDDT.S530823","article-title":"DHLCA alleviates diabetic kidney disease via TGR5\/FXR activation and gut microbiota remodeling","volume":"19","author":"Zhou","year":"2025","journal-title":"Drug Des Devel Ther."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1441415","DOI":"10.3389\/fendo.2024.1441415","article-title":"Intestinal flora and bile acid interactions impact the progression of diabetic kidney disease","volume":"15","author":"Xu","year":"2024","journal-title":"Front Endocrinol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.2337\/db13-0639","article-title":"Human insulin resistance is associated with increased plasma levels of 12\u03b1-hydroxylated bile acids","volume":"62","author":"Haeusler","year":"2013","journal-title":"Diabetes."},{"key":"B202","doi-asserted-by":"publisher","first-page":"112393","DOI":"10.1016\/j.exger.2024.112393","article-title":"Tangshen Formula alleviates inflammatory injury against aged diabetic kidney disease through modulating gut microbiota composition and related amino acid metabolism","volume":"188","author":"Chen","year":"2024","journal-title":"Exp Gerontol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.29857","article-title":"Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism","volume":"68","author":"Pathak","year":"2018","journal-title":"Hepatology."},{"key":"B204","doi-asserted-by":"publisher","first-page":"816","DOI":"10.7150\/ijms.25543","article-title":"Intestinal dysbiosis activates renal renin-angiotensin system contributing to incipient diabetic nephropathy","volume":"15","author":"Lu","year":"2018","journal-title":"Int J Med Sci."},{"key":"B205","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1016\/j.ekir.2024.08.002","article-title":"Role of bile acid receptors in the development and function of diabetic nephropathy","volume":"9","author":"Fang","year":"2024","journal-title":"Kidney Int Rep."},{"key":"B206","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1681\/ASN.2017020222","article-title":"FXR\/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity","volume":"29","author":"Wang","year":"2018","journal-title":"J Am Soc Nephrol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1681\/ASN.2014121271","article-title":"G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes","volume":"27","author":"Wang","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"116257","DOI":"10.1016\/j.jep.2023.116257","article-title":"Yi-Shen-Hua-Shi granule ameliorates diabetic kidney disease by the \u201cgut-kidney axis\u201d","volume":"307","author":"Han","year":"2023","journal-title":"J Ethnopharmacol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41581-019-0172-1","article-title":"Intestinal microbiome and fitness in kidney disease","volume":"15","author":"Meijers","year":"2019","journal-title":"Nat Rev Nephrol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"9517","DOI":"10.1021\/jf402506c","article-title":"Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition","volume":"61","author":"Etxeberria","year":"2013","journal-title":"J Agric Food Chem."},{"key":"B211","doi-asserted-by":"publisher","first-page":"156801","DOI":"10.1016\/j.phymed.2025.156801","article-title":"Quercetin ameliorates hyperuricemic nephropathy through improving gut dysfunctions and decreasing gut bacteria-derived uremic toxins","volume":"143","author":"Peng","year":"2025","journal-title":"Phytomedicine."},{"key":"B212","doi-asserted-by":"publisher","first-page":"983358","DOI":"10.3389\/fmicb.2022.983358","article-title":"Quercetin positively affects gene expression profiles and metabolic pathway of antibiotic-treated mouse gut microbiota","volume":"13","author":"Mi","year":"2022","journal-title":"Front Microbiol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40104-020-00492-9","article-title":"Dietary protocatechuic acid ameliorates inflammation and up-regulates intestinal tight junction proteins by modulating gut microbiota in LPS-challenged piglets","volume":"11","author":"Hu","year":"2020","journal-title":"J Anim Sci Biotechnol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"105444","DOI":"10.1016\/j.phrs.2021.105444","article-title":"Baicalin and the liver-gut system: pharmacological bases explaining its therapeutic effects","volume":"165","author":"Hu","year":"2021","journal-title":"Pharmacol Res."},{"key":"B215","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1080\/09168451.2018.1444467","article-title":"Flavonoid metabolism: the interaction of metabolites and gut microbiota","volume":"82","author":"Murota","year":"2018","journal-title":"Biosci Biotechnol Biochem."},{"key":"B216","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.freeradbiomed.2019.04.005","article-title":"Gut microbiota modulation and anti-inflammatory properties of anthocyanins from the fruits of Lycium ruthenicum Murray in dextran sodium sulfate-induced colitis in mice","volume":"136","author":"Peng","year":"2019","journal-title":"Free Radic Biol Med."},{"key":"B217","doi-asserted-by":"publisher","first-page":"693048","DOI":"10.3389\/fphar.2021.693048","article-title":"Chlorogenic acid improves NAFLD by regulating gut microbiota and GLP-1","volume":"12","author":"Shi","year":"2021","journal-title":"Front Pharmacol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1148737","DOI":"10.3389\/fphar.2023.1148737","article-title":"Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"31790","DOI":"10.18632\/oncotarget.9306","article-title":"Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget."},{"key":"B220","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fphar.2020.00833","article-title":"Integrated metagenomic and metabolomic analyses of the effect of astragalus polysaccharides on alleviating high-fat diet-induced metabolic disorders","volume":"11","author":"Hong","year":"2020","journal-title":"Front Pharmacol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"e0303924","DOI":"10.1128\/spectrum.03039-24","article-title":"Synergistic gut microbiome-mediated degradation of Astragalus membranaceus polysaccharides and Codonopsis pilosula polysaccharides into butyric acid: a metatranscriptomic analysis","volume":"13","author":"Rong","year":"2025","journal-title":"Microbiol Spectr."},{"key":"B223","doi-asserted-by":"publisher","first-page":"2290213","DOI":"10.1080\/07853890.2023.2290213","article-title":"Lycium barbarum polysaccharide alleviates DSS-induced chronic ulcerative colitis by restoring intestinal barrier function and modulating gut microbiota","volume":"55","author":"Li","year":"2023","journal-title":"Ann Med."},{"key":"B224","doi-asserted-by":"publisher","first-page":"154626","DOI":"10.1016\/j.phymed.2022.154626","article-title":"Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-\u03b2\/Smad signaling","volume":"110","author":"Chen","year":"2023","journal-title":"Phytomedicine."},{"key":"B225","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2215\/CJN.05240515","article-title":"Synbiotics easing renal failure by improving gut microbiology (SYNERGY): a randomized trial","volume":"11","author":"Rossi","year":"2016","journal-title":"Clin J Am Soc Nephrol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fphar.2018.00557","article-title":"Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders","volume":"9","author":"Neag","year":"2018","journal-title":"Front Pharmacol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"104722","DOI":"10.1016\/j.phrs.2020.104722","article-title":"Berberine pharmacology and the gut microbiota: a hidden therapeutic link","volume":"155","author":"Habtemariam","year":"2020","journal-title":"Pharmacol Res."},{"key":"B228","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1038\/s41467-020-18414-8","article-title":"Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun."},{"key":"B229","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.phytochem.2011.02.012","article-title":"Ginsenosides from American ginseng: chemical and pharmacological diversity","volume":"72","author":"Qi","year":"2011","journal-title":"Phytochemistry."},{"key":"B230","doi-asserted-by":"publisher","first-page":"826487","DOI":"10.3389\/fmicb.2022.826487","article-title":"Ginsenoside Rb1 improves metabolic disorder in high-fat diet-induced obese mice associated with modulation of gut microbiota","volume":"13","author":"Zou","year":"2022","journal-title":"Front Microbiol."},{"key":"B231","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/cells8030204","article-title":"Ginsenoside Rb1 as an anti-diabetic agent and its underlying mechanism analysis","volume":"8","author":"Zhou","year":"2019","journal-title":"Cells."},{"key":"B232","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/00365599.2011.585622","article-title":"Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-\u03b2 and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study","volume":"45","author":"Khajehdehi","year":"2011","journal-title":"Scand J Urol Nephrol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"1361780","DOI":"10.1080\/16546628.2017.1361780","article-title":"Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications","volume":"61","author":"Shen","year":"2017","journal-title":"Food Nutr Res."},{"key":"B234","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1038\/s41598-018-21421-x","article-title":"Hypoglycemic and hypolipidemic effect of S-allyl-cysteine sulfoxide (alliin) in DIO mice","volume":"8","author":"Zhai","year":"2018","journal-title":"Sci Rep."},{"key":"B235","doi-asserted-by":"publisher","first-page":"401630","DOI":"10.1155\/2015\/401630","article-title":"Immunomodulation and anti-inflammatory effects of garlic compounds","volume":"2015","author":"Arreola","year":"2015","journal-title":"J Immunol Res."},{"key":"B236","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/ajcn\/79.5.727","article-title":"Polyphenols: food sources and bioavailability","volume":"79","author":"Manach","year":"2004","journal-title":"Am J Clin Nutr."},{"key":"B237","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: an overview","volume":"5","author":"Panche","year":"2016","journal-title":"J Nutr Sci."},{"key":"B238","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejphar.2008.03.008","article-title":"Health effects of quercetin: from antioxidant to nutraceutical","volume":"585","author":"Boots","year":"2008","journal-title":"Eur J Pharmacol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"Anand","year":"2007","journal-title":"Mol Pharm."},{"key":"B240","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/S0142-9612(03)00213-8","article-title":"Pectin-based systems for colon-specific drug delivery via oral route","volume":"24","author":"Liu","year":"2003","journal-title":"Biomaterials."},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/81.1.230S","article-title":"Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies","author":"Manach","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"B242","doi-asserted-by":"publisher","first-page":"eaag2770","DOI":"10.1126\/science.aag2770","article-title":"Chemical transformation of xenobiotics by the human gut microbiota","volume":"356","author":"Koppel","year":"2017","journal-title":"Science"},{"key":"B243","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1021\/jf902107d","article-title":"Interaction between phenolics and gut microbiota: role in human health","volume":"57","author":"Selma","year":"2009","journal-title":"J Agric Food Chem."},{"key":"B244","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/19490976.2016.1158395","article-title":"Bacterial species involved in the conversion of dietary flavonoids in the human gut","volume":"7","author":"Braune","year":"2016","journal-title":"Gut Microbes."},{"key":"B245","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1021\/jf3002153","article-title":"Metabolism of anthocyanins by human gut microflora and their influence on gut bacterial growth","volume":"60","author":"Hidalgo","year":"2012","journal-title":"J Agric Food Chem."},{"key":"B246","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1248\/bpb.21.245","article-title":"Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration\u2013measurement of compound K by enzyme immunoassay","volume":"21","author":"Akao","year":"1998","journal-title":"Biol Pharm Bull."},{"key":"B247","doi-asserted-by":"publisher","first-page":"e62409","DOI":"10.1371\/journal.pone.0062409","article-title":"Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS ONE."},{"key":"B248","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s42255-019-0073-4","article-title":"The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans","volume":"1","author":"Andreux","year":"2019","journal-title":"Nat Metab."},{"key":"B249","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1093\/jn\/132.12.3577","article-title":"The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones","volume":"132","author":"Setchell","year":"2002","journal-title":"J Nutr."},{"key":"B250","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-food-032519-051834","article-title":"Enhancing efficacy, performance, and reliability of cannabis edibles: insights from lipid bioavailability studies","volume":"11","author":"McClements","year":"2020","journal-title":"Annu Rev Food Sci Technol."},{"key":"B251","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.colsurfb.2016.06.053","article-title":"Biopolymer nano-particles and natural nano-carriers for nano-encapsulation of phenolic compounds","volume":"146","author":"Faridi Esfanjani","year":"2016","journal-title":"Colloids Surf B Biointerfaces."},{"key":"B252","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1021\/jf205238x","article-title":"Nanoparticles synthesized from soy protein: preparation, characterization, and application for nutraceutical encapsulation","volume":"60","author":"Teng","year":"2012","journal-title":"J Agric Food Chem."},{"key":"B253","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1079\/BJN20061809","article-title":"Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions","volume":"96","author":"Mullen","year":"2006","journal-title":"Br J Nutr."},{"key":"B254","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach","volume":"116","author":"des Rieux","year":"2006","journal-title":"J Control Release"},{"key":"B255","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1021\/np1007262","article-title":"Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation","volume":"74","author":"Cuomo","year":"2011","journal-title":"J Nat Prod."},{"key":"B256","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.fitote.2009.11.001","article-title":"Supramolecular phospholipids-polyphenolics interactions: the PHYTOSOME strategy to improve the bioavailability of phytochemicals","volume":"81","author":"Semalty","year":"2010","journal-title":"Fitoterapia."},{"key":"B257","doi-asserted-by":"publisher","first-page":"107689","DOI":"10.1016\/j.pharmthera.2020.107689","article-title":"Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping","volume":"218","author":"Miners","year":"2021","journal-title":"Pharmacol Ther."},{"key":"B258","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1073\/pnas.1215927110","article-title":"Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation","volume":"110","author":"Pluznick","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B259","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00228-011-1108-2","article-title":"Repeated administration of berberine inhibits cytochromes P450 in humans","volume":"68","author":"Guo","year":"2012","journal-title":"Eur J Clin Pharmacol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jep.2014.09.049","article-title":"Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension","volume":"161","author":"Lan","year":"2015","journal-title":"J Ethnopharmacol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/clpt.2010.298","article-title":"Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review","volume":"89","author":"Zhao","year":"2011","journal-title":"Clin Pharmacol Ther."},{"key":"B262","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/med.21431","article-title":"Understanding the molecular mechanisms of the interplay between herbal medicines and gut microbiota","volume":"37","author":"Xu","year":"2017","journal-title":"Med Res Rev."},{"key":"B263","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.drudis.2018.11.014","article-title":"Artificial intelligence in drug development: present status and future prospects","volume":"24","author":"Mak","year":"2019","journal-title":"Drug Discov Today."},{"key":"B264","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.kint.2016.03.041","article-title":"Nanomedicines for kidney diseases","volume":"90","author":"Williams","year":"2016","journal-title":"Kidney Int."},{"key":"B265","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1073\/pnas.1103573108","article-title":"Targeting kidney mesangium by nanoparticles of defined size","volume":"108","author":"Choi","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B266","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.apsb.2020.12.020","article-title":"Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management","volume":"11","author":"Tang","year":"2021","journal-title":"Acta Pharm Sin B."},{"key":"B267","doi-asserted-by":"publisher","first-page":"1400939","DOI":"10.3389\/fendo.2024.1400939","article-title":"Efficacy and safety of the traditional Chinese formula Shengjiang powder combined with conventional therapy in the treatment of diabetic kidney disease: a systematic review and meta-analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol."},{"key":"B268","doi-asserted-by":"publisher","first-page":"1055296","DOI":"10.3389\/fphar.2022.1055296","article-title":"Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol."},{"key":"B269","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jep.2010.10.012","article-title":"Meta-analysis of the clinical value of Astragalus membranaceus in diabetic nephropathy","volume":"133","author":"Li","year":"2011","journal-title":"J Ethnopharmacol."},{"key":"B270","doi-asserted-by":"publisher","first-page":"2359033","DOI":"10.1080\/0886022X.2024.2359033","article-title":"Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis","volume":"46","author":"Lin","year":"2024","journal-title":"Ren Fail."},{"key":"B271","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2147\/DDDT.S411211","article-title":"Astragalus polysaccharide ameliorates renal inflammatory responses in a diabetic nephropathy by suppressing the TLR4\/NF-\u03baB pathway","volume":"17","author":"Guo","year":"2023","journal-title":"Drug Des Devel Ther."},{"key":"B272","first-page":"311","article-title":"Momordica charantia L lowers elevated glycaemia in type 2 diabetes mellitus patients: systematic review and meta-analysis","volume-title":"J Ethnopharmacol.","author":"Peter","year":"2019"},{"key":"B273","doi-asserted-by":"publisher","first-page":"1383801","DOI":"10.3389\/fvets.2024.1383801","article-title":"A study on the treatment effects of Crataegus pinnatifida polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota","volume":"11","author":"Hao","year":"2024","journal-title":"Front Vet Sci."},{"key":"B274","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","author":"Kidney","year":"2022","journal-title":"Kidney Int"},{"key":"B275","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41581-020-0297-2","article-title":"Plant-based diets to manage the risks and complications of chronic kidney disease","volume":"16","author":"Carrero","year":"2020","journal-title":"Nat Rev Nephrol."},{"key":"B276","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney","year":"2024","journal-title":"Kidney Int"},{"key":"B277","doi-asserted-by":"publisher","first-page":"1408424","DOI":"10.3389\/fnut.2024.1408424","article-title":"Association between dietary protein intake and risk of chronic kidney disease: a systematic review and meta-analysis","volume":"11","author":"Cheng","year":"2024","journal-title":"Front Nutr."},{"key":"B278","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","article-title":"Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease","volume":"97","author":"Gryp","year":"2020","journal-title":"Kidney Int."},{"key":"B279","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.3390\/ijms21061986","article-title":"Isolation and quantification of uremic toxin precursor-generating gut bacteria in chronic kidney disease patients","volume":"21","author":"Gryp","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B280","doi-asserted-by":"publisher","first-page":"e2426577","DOI":"10.1001\/jamanetworkopen.2024.26577","article-title":"Protein intake and mortality in older adults with chronic kidney disease","volume":"7","author":"Carballo-Casla","year":"2024","journal-title":"JAMA Netw Open."},{"key":"B281","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clnesp.2022.01.030","article-title":"The differential effect of animal versus vegetable dietary protein on the clinical manifestations of diabetic kidney disease in humans","volume":"48","author":"Adeva-Andany","year":"2022","journal-title":"Clin Nutr ESPEN."},{"key":"B282","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1053\/j.ajkd.2023.05.007","article-title":"Association of plant protein intake with risk of incident CKD: a UK Biobank study","volume":"82","author":"Heo","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"B283","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12882-020-02079-y","article-title":"A prospective study on total protein, plant protein and animal protein in relation to the risk of incident chronic kidney disease","volume":"21","author":"Alvirdizadeh","year":"2020","journal-title":"BMC Nephrol."},{"key":"B284","doi-asserted-by":"publisher","first-page":"2479573","DOI":"10.1080\/0886022X.2025.2479573","article-title":"Analysis of correlation between dietary fiber intake and risk of diabetic kidney disease in adults with type 2 diabetes mellitus: results from the United States National Health and Nutrition Examination Surveys 2009-2018","volume":"47","author":"Luo","year":"2025","journal-title":"Ren Fail."},{"key":"B285","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12916-024-03455-3","article-title":"Adherence to a Mediterranean diet is associated with a lower risk of diabetic kidney disease among individuals with hyperglycemia: a prospective cohort study","volume":"22","author":"Qu","year":"2024","journal-title":"BMC Med."},{"key":"B286","doi-asserted-by":"publisher","first-page":"1463502","DOI":"10.3389\/fnut.2024.1463502","article-title":"Safety and impact of the Mediterranean diet in patients with chronic kidney disease: a pilot randomized crossover trial","volume":"11","author":"Kwon","year":"2024","journal-title":"Front Nutr."},{"key":"B287","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41387-024-00285-3","article-title":"Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial","volume":"14","author":"Podadera-Herreros","year":"2024","journal-title":"Nutr Diabetes."},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303343599250210103212","article-title":"Akkermansia muciniphila delays the progression of diabetic nephropathy by reducing the accumulation of uremic toxins in the feces and peripheral blood","author":"Song","year":"2025","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B289","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.3390\/jcm10194456","article-title":"Effects of probiotics, prebiotics, and synbiotics on uremic toxins, inflammation, and oxidative stress in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Nguyen","year":"2021","journal-title":"J Clin Med."},{"key":"B290","doi-asserted-by":"publisher","first-page":"4545595","DOI":"10.1155\/2024\/4545595","article-title":"Genetic evidence for the causal relationship between gut microbiota and diabetic kidney disease: a bidirectional, two-sample Mendelian randomisation study","volume":"2024","author":"Zhang","year":"2024","journal-title":"J Diabetes Res."},{"key":"B291","doi-asserted-by":"publisher","first-page":"1329954","DOI":"10.3389\/fendo.2024.1329954","article-title":"Assessing the causal relationship between gut microbiota and diabetic nephropathy: insights from two-sample Mendelian randomization","volume":"15","author":"Fang","year":"2024","journal-title":"Front Endocrinol."},{"key":"B292","doi-asserted-by":"publisher","first-page":"1434613","DOI":"10.3389\/fnut.2024.1434613","article-title":"Efficacy of probiotics\/synbiotics supplementation in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Liu","year":"2024","journal-title":"Front Nutr."},{"key":"B293","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41591-020-0934-0","article-title":"Human postprandial responses to food and potential for precision nutrition","volume":"26","author":"Berry","year":"2020","journal-title":"Nat Med."},{"key":"B294","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/10408398.2020.1740645","article-title":"Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"61","author":"Zheng","year":"2021","journal-title":"Crit Rev Food Sci Nutr."},{"key":"B295","doi-asserted-by":"publisher","first-page":"1185317","DOI":"10.3389\/fimmu.2023.1185317","article-title":"Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols","volume":"14","author":"Jin","year":"2023","journal-title":"Front Immunol."},{"key":"B296","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/toxins13040252","article-title":"The impact of CKD on uremic toxins and gut microbiota","volume":"13","author":"Rysz","year":"2021","journal-title":"Toxins."},{"key":"B297","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41579-023-00998-9","article-title":"Utilization of the microbiome in personalized medicine","volume":"22","author":"Ratiner","year":"2024","journal-title":"Nat Rev Microbiol."},{"key":"B298","doi-asserted-by":"publisher","first-page":"e2200476","DOI":"10.1002\/mnfr.202200476","article-title":"Gut microbiome analysis for personalized nutrition: the state of science","volume":"67","year":"2023","journal-title":"Mol Nutr Food Res."},{"key":"B299","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1053\/j.jrn.2022.04.001","article-title":"Probiotics, prebiotics, and synbiotics for patients on dialysis: a systematic review and meta-analysis of randomized controlled trials","volume":"33","author":"Chen","year":"2023","journal-title":"J Ren Nutr."},{"key":"B300","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized nutrition by prediction of glycemic responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell."},{"key":"B301","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.123.067584","article-title":"Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria","volume":"149","author":"Neuen","year":"2024","journal-title":"Circulation"},{"key":"B302","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1002\/fsn3.3983","article-title":"Dietary phenolic compounds as promising therapeutic agents for diabetes and its complications: a comprehensive review","volume":"12","author":"Aryal","year":"2024","journal-title":"Food Sci Nutr."},{"key":"B303","doi-asserted-by":"publisher","first-page":"Cd013631","DOI":"10.1002\/14651858.CD013631.pub2","article-title":"Synbiotics, prebiotics and probiotics for people with chronic kidney disease","volume":"10","author":"Cooper","year":"2023","journal-title":"Cochrane Database Syst Rev."},{"key":"B304","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jnutbio.2014.10.008","article-title":"Endogenous and exogenous mediators of quercetin bioavailability","volume":"26","author":"Guo","year":"2015","journal-title":"J Nutr Biochem."},{"key":"B305","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/ajhp\/61.22.2406","article-title":"Effect of quercetin on the pharmacokinetics of oral cyclosporine","volume":"61","author":"Choi","year":"2004","journal-title":"Am J Health Syst Pharm."},{"key":"B306","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40262-013-0126-x","article-title":"Pharmacokinetic and pharmacodynamic profile of empagliflozin, a sodium glucose co-transporter 2 inhibitor","volume":"53","author":"Scheen","year":"2014","journal-title":"Clin Pharmacokinet."},{"key":"B307","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1021\/jf0006832","article-title":"Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism","volume":"48","author":"Kobayashi","year":"2000","journal-title":"J Agric Food Chem."},{"key":"B308","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/cvr\/cvaa064","article-title":"Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stress","volume":"117","author":"Packer","year":"2021","journal-title":"Cardiovasc Res."},{"key":"B309","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3389\/fphar.2017.00336","article-title":"Quercetin, a lead compound against type 2 diabetes ameliorates glucose uptake via AMPK pathway in skeletal muscle cell line","volume":"8","author":"Dhanya","year":"2017","journal-title":"Front Pharmacol."},{"key":"B310","doi-asserted-by":"publisher","first-page":"e99123","DOI":"10.1172\/jci.insight.99123","article-title":"Canagliflozin triggers the FGF23\/1,25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study","volume":"3","author":"Blau","year":"2018","journal-title":"JCI Insight."},{"key":"B311","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.2337\/db15-1356","article-title":"Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes","volume":"65","author":"Ferrannini","year":"2016","journal-title":"Diabetes."},{"key":"B312","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/toxins12090590","article-title":"Gut-derived protein-bound uremic toxins","volume":"12","author":"Graboski","year":"2020","journal-title":"Toxins."},{"key":"B313","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.2147\/DMSO.S320169","article-title":"The profile and function of gut microbiota in diabetic nephropathy","volume":"14","author":"Chen","year":"2021","journal-title":"Diabetes Metab Syndr Obes."},{"key":"B314","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.tifs.2017.07.008","article-title":"Rutin: a review on extraction, identification and purification methods, biological activities and approaches to enhance its bioavailability","volume":"67","author":"Gull\u00f3n","year":"2017","journal-title":"Trends Food Sci Technol."},{"key":"B315","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00394-017-1379-1","article-title":"The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: a comprehensive review of the literature","volume":"56","author":"Tajik","year":"2017","journal-title":"Eur J Nutr."},{"key":"B316","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000491755","article-title":"Antioxidant properties of ferulic acid and its possible application","volume":"31","author":"Zdu\u0144ska","year":"2018","journal-title":"Skin Pharmacol Physiol."},{"key":"B317","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/nu5041417","article-title":"Fiber and prebiotics: mechanisms and health benefits","volume":"5","author":"Slavin","year":"2013","journal-title":"Nutrients."},{"key":"B318","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1530\/EC-14-0036","article-title":"Efficacy of increased resistant starch consumption in human type 2 diabetes","volume":"3","author":"Bodinham","year":"2014","journal-title":"Endocr Connect."},{"key":"B319","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jgr.2015.04.009","article-title":"Characterization of Korean Red Ginseng (Panax ginseng Meyer): history, preparation method, and chemical composition","volume":"39","author":"Lee","year":"2015","journal-title":"J Ginseng Res."},{"key":"B320","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/nure.12012","article-title":"Effect of garlic on serum lipids: an updated meta-analysis","volume":"71","author":"Ried","year":"2013","journal-title":"Nutr Rev."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1778473\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:51:16Z","timestamp":1777351876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1778473\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":320,"alternative-id":["10.3389\/fnut.2026.1778473"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1778473","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"article-number":"1778473"}}